CATALOGO DEI PRODOTTI DELLA RICERCA

BENCIVENGA, Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.717
EU - Europa 1.496
AS - Asia 601
AF - Africa 21
OC - Oceania 9
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.854
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.711
CN - Cina 481
GB - Regno Unito 441
IE - Irlanda 210
SE - Svezia 210
IT - Italia 208
FR - Francia 162
DE - Germania 95
FI - Finlandia 68
VN - Vietnam 52
UA - Ucraina 34
KR - Corea 27
RW - Ruanda 21
AT - Austria 16
BE - Belgio 15
HK - Hong Kong 12
RU - Federazione Russa 10
AU - Australia 8
CA - Canada 6
NL - Olanda 6
TW - Taiwan 6
ES - Italia 5
IL - Israele 5
SG - Singapore 4
EU - Europa 3
JP - Giappone 3
PE - Perù 3
TR - Turchia 3
AZ - Azerbaigian 2
BR - Brasile 2
LU - Lussemburgo 2
NO - Norvegia 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BO - Bolivia 1
CH - Svizzera 1
CL - Cile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EE - Estonia 1
GR - Grecia 1
HU - Ungheria 1
ID - Indonesia 1
IN - India 1
KH - Cambogia 1
LK - Sri Lanka 1
LV - Lettonia 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
TH - Thailandia 1
Totale 3.854
Salva come PNG Salva come JPEG
Città #
Southend 413
Chandler 407
Dublin 206
Jacksonville 156
Ashburn 123
Beijing 98
Ann Arbor 92
Verona 86
Redmond 78
New York 76
Woodbridge 73
Lawrence 62
Princeton 62
Houston 60
Jinan 53
Wilmington 48
Helsinki 42
Nanjing 42
Shenyang 37
Hebei 27
Seoul 27
Sindelfingen 27
Dong Ket 24
Kigali 21
Los Angeles 19
Changsha 18
Tianjin 17
Falls Church 16
Haikou 16
Brussels 15
Guangzhou 15
Nanchang 15
Ningbo 14
Taizhou 14
Seattle 13
Hong Kong 12
Vienna 12
Zhengzhou 12
Jiaxing 11
Washington 11
Hangzhou 10
Milan 10
Fuzhou 9
Redwood City 8
Auburn Hills 6
Erba 6
Lancaster 6
Norwalk 6
Renton 6
San Francisco 6
Tombolo 6
Amsterdam 4
Bologna 4
Cagliari 4
Klagenfurt 4
Lappeenranta 4
Paris 4
Sant'Ambrogio di Valpolicella 4
Singapore 4
Tel Aviv 4
Adelaide 3
Boardman 3
Detroit 3
Dongguan 3
Frankfurt am Main 3
Lima 3
Melbourne 3
San Diego 3
Toronto 3
Trento 3
Ancona 2
Baku 2
Bassano del Grappa 2
Berlin 2
Boydton 2
Caneva 2
Chions 2
Clearwater 2
Columbus 2
Council Bluffs 2
Düsseldorf 2
Falkenstein 2
Fortaleza 2
Gipuzkoa 2
Grafing 2
Groningen 2
Kemerovo 2
Lanzhou 2
London 2
Luxembourg 2
Markham 2
Mehlingen 2
Oslo 2
Para 2
Saga 2
Scottsdale 2
Taiyuan 2
Udine 2
Xiangfen 2
Aosta 1
Totale 2.774
Salva come PNG Salva come JPEG
Nome #
High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers 126
Shape and volume of internal anal sphincter showed by three-dimensional anorectal ultrasonography 125
Proton Magnetic Resonance Spectroscopy: Ex vivo study to investigate its prognostic role in colorectal cancer. 119
Impact of super-extended lymphadenectomy on relapse in advanced gastric cancer. 115
Genomic characterization of hepatoid tumors: context matters 100
TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients 92
Extension of lymphadenectomy for gastric cancer:Audit at European specialist centres. 92
Targeted therapies for advanced and metastatic adenocarcinoma of the gastroesophageal junction: is there something new? 86
Enhanced recovery after surgery protocol in patients undergoing esophagectomy for cancer: a single center experience 85
The amount of cells with Signet Ring Cell morphology has a prognostic impact in poorly cohesive gastric carcinoma 82
One stage or two stage treatment of colorectal cancer associated to abdominal aortic aneurysm: morbidity and mortality. 81
Lymphadenectomy for gastric cancer at European specialist centres 81
Short-term and long-term risk factors in gastric cancer 80
Extranodal Extension of Nodal Metastases Is a Poor Prognostic Indicator in Gastric Cancer: a Systematic Review and Meta-analysis 79
Pretreatment Primary Tumor Stage is a Risk Factor for Recurrence in Patients with Esophageal Squamous Cell Carcinoma Who Achieve Pathological Complete Response After Neoadjuvant Chemoradiotherapy 76
Western strategy for EGJ carcinoma 74
Lymphadenectomy: how to do it? 73
The amount of signet ring cells is significantly associated with tumour stage and survival in gastric poorly cohesive tumours 70
hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett's esophagus and can be exploited for a novel endoscopic surveillance 67
Management of critically ill surgical patients Case reports 67
Acute bleeding obstruction pancreatitis after Roux-en-Y anastomosis in total gastrectomy: a single center experience 67
Gastric stump cancer after distal gastrectomy for benign disease: clinicopathological features and surgical outcomes. 66
Do all the European surgeons perform the same D2? The need of D2 audit in Europe 65
Multicenter Study of Presentation, Management, and Postoperative and Long-Term Outcomes of Septegenerians and Octogenerians Undergoing Gastrectomy for Gastric Cancer 65
Is there any role for super-extended limphadenectomy in advanced gastric cancer? results of an observational study from a western high volume center 65
Complications after gastrectomy for cancer: Italian perspective 64
Clinical pathways in gastric cancer care 63
Limited Usefulness of 18F-FDG PET/CT in Predicting Tumor Regression After Preoperative Chemotherapy for Noncardia Gastric Cancer: The Italian Research Group for Gastric Cancer (GIRCG) Experience 63
A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal-gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial 61
Methylation Dynamics of RASSF1A and Its Impact on Cancer 59
Conversion gastrectomy for stage IV unresectable gastric cancer: a GIRCG retrospective cohort study 58
Laparoscopic transhiatal suture and gastric valve as a safe and feasible treatment for Boerhaave's syndrome: an Italian single center case series study 57
Validation of two prognostic models for recurrence and survival after radical gastrectomy for gastric cancer 56
ASO Author Reflections: Recurrence After Pathological Complete Response in Esophageal Cancer: Analysis of Risk Factors for this Unexpected Event 56
Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer 52
Perianastomotic drainage in Ivor-Lewis esophagectomy, does habit affect utility? An 11-year single-center experience 52
Para-aortic lymphadenectomy in surgery for gastric cancer: current indications and future perspectives 51
Tailored treatment for signet ring cell gastric cancer 51
Gastric Cancer Maximum Tumour Diameter Reduction Rate at CT Examination as a Radiological Index for Predicting Histopathological Regression after Neoadjuvant Treatment: A Multicentre GIRCG Study 51
Surgical treatment of hepatic metastases from gastric cancer 49
An aggressive early gastric cancer: Kodama's PenA type 49
Recurrence in node-negative advanced gastric cancer: Novel findings from an in-depth pathological analysis of prognostic factors from a multicentric series 45
Turning left or right? A comparative analysis in adenocarcinomas of the esophagogastric junction according to the seventh AJCC TNM classification for cancers of the esophagus and stomach: experience in a Chinese single institution 45
Mucin expression in gastric- and gastro-oesophageal signet-ring cell cancer: results from a comprehensive literature review and a large cohort study of Caucasian and Asian gastric cancer 43
Stage IV Gastric Cancer: The Surgical Perspective of the Italian Research Group on Gastric Cancer 42
Extended lymphadenectomy in elderly and/or highly co-morbid gastric cancer patients: A retrospective multicenter study 42
Personalized therapeutic strategies in HER2-driven gastric cancer 41
A therapeutic perspective for proliferative vitreoretinopathy based on the inhibition of epithelial-mesenchymal transition by miR-194 40
Palliation with a multimodality treatment including hypoxic pelvic perfusion for unresectable recurrent rectal cancer: outcomes based on a retrospective study 40
A national survey on the current status of minimally invasive gastric practice on behalf of GIRCG 37
Preoperative or Perioperative Docetaxel, Oxaliplatin, and Capecitabine (GASTRODOC Regimen) in Patients with Locally-Advanced Resectable Gastric Cancer: A Randomized Phase-II Trial 36
Poorly Cohesive Gastric Cancers Showing the Transcriptomic Hallmarks of Epithelial-Mesenchymal Transition Behave Aggressively 36
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in multimodal therapy for patients with oligometastatic peritoneal gastric cancer: a randomized multicenter phase III trial PIPAC VEROne 35
A Comprehensive PDX Gastric Cancer Collection Captures Cancer Cell-Intrinsic Transcriptional MSI Traits 35
Multigene Panel Testing Increases the Number of Loci Associated with Gastric Cancer Predisposition 35
Looking for a strategy in treating peritoneal gastric cancer carcinomatosis: an Italian multicenter Gastric Cancer Research group's analysis 33
Consequences of the COVID-19 pandemic on the diagnosis and treatment of gastric cancer in referral centers in Italy 33
Current practice on the use of prophylactic drain after gastrectomy in Italy: the Abdominal Drain in Gastrectomy (ADiGe) survey 32
Development and validation of a pretreatment nomogram to predict overall survival in gastric cancer 31
Which gastric cancer patients could benefit from staging laparoscopy? A GIRCG multicenter cohort study 31
The hERG1 Potassium Channel Behaves As Prognostic Factor In Gastric Dysplasia Endoscopic Samples 30
Molecular Analysis of an Intestinal Neuroendocrine/Non-neuroendocrine Neoplasm (MiNEN) Reveals MLH1 Methylation-driven Microsatellite Instability and a Monoclonal Origin: Diagnostic and Clinical Implications 27
On the road to standardization of D2 lymph node dissection in a European population of patients with gastric cancer 24
Optimized EGFR Blockade Strategies in EGFR Addicted Gastroesophageal Adenocarcinomas 24
Development and validation of pretreatment nomogram for disease-specific mortality in gastric cancer-A competing risk analysis 21
Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe 18
Treatment of EGJ Cancer within or outside clinical trials: Does the setting matter? A monocentric prospective observational study 17
Management, short and long-term outcomes in septegenerians and octegenerians undergoing gastrectomy for cancer 15
Landscape of Druggable Molecular Pathways Downstream of Genomic CDH1/Cadherin-1 Alterations in Gastric Cancer 15
Validating a nodal regression system for gastric cancer: An ancillary cohort study of the GASTRODOC trial 14
Beyond years: evaluating the impact of surgeon age on outcomes after gastric cancer surgery 13
Bidirectional Approach with PIPAC and Systemic Chemotherapy for Patients with Synchronous Gastric Cancer Peritoneal Metastases (GCPM) 11
Robotic versus open Ivor-Lewis esophagectomy: A more accurate lymph node dissection without burdening the leak rate 9
Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in Europe 8
Prophylactic Total Gastrectomy: Techniques 8
Clinical Features of Gastric Signet Ring Cell Cancer: Results from a Systematic Review and Meta-Analysis 8
YAP Activation Is Associated with a Worse Prognosis of Poorly Cohesive Gastric Cancer 6
ASO Visual Abstract: Bidirectional Approach with PIPAC and Systemic Chemotherapy for Patients with Synchronous Gastric Cancer Peritoneal Metastases (GCPM) 6
Targeting FGFR Pathway Is Not an Effective Therapeutic Strategy in Patients with Unselected Metastatic Esophagogastric Cancer Resistant to Trastuzumab 4
Influence of Tumor Stroma on the Aggressiveness of Poorly Cohesive Gastric Carcinoma 4
Primary Tumor Resection for Metastatic Colorectal, Gastric and Pancreatic Cancer Patients: In Search of Scientific Evidence to Inform Clinical Practice 4
A pragmatic approach improves the clinical management of stage IV gastric cancer: Comparison between the Meta-Gastro results and the GIRCG's retrospective series 3
Oligometastatic Gastric Cancer: Clinical Data from the Meta-Gastro Prospective Register of the Italian Research Group on Gastric Cancer 3
International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape : Bertinoro Workshop, November 2022 1
VEGFA Status as a Predictive Marker of Therapy Outcome in Metastatic Gastric Cancer Patients Following Ramucirumab-Based Treatment 1
Totale 3.996
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.610
article - articoli 14.064
book - libri 0
conference - conferenze 230
curatela - curatele 0
other - altro 263
patent - brevetti 0
selected - selezionate 0
volume - volumi 53
Totale 29.220
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20199 0 0 0 0 0 0 0 0 0 0 3 6
2019/2020472 43 6 3 20 51 28 65 45 16 52 49 94
2020/2021511 83 63 20 81 58 47 4 5 21 10 66 53
2021/2022534 25 120 26 42 33 23 8 41 18 30 30 138
2022/20231.276 73 140 102 217 105 319 7 104 129 11 32 37
2023/2024643 17 58 57 97 65 168 40 47 16 75 3 0
Totale 3.996